This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in 2020.
Format:
Report
Publication Date:
2019
ID:
347004
- Physicians
- International Agencies
- TB
- Extensively Drug-Resistant TB (XDR TB)
- MDR TB
- TB Treatment
- Treatment Guidelines Materials